Ofatumumab versus rituximab salvage chemoimmunotherapy in relapsed or refractory diffuse large B-cell lymphoma: The Orcharrd Study (OMB110928) Meeting Abstract


Authors: van Imhoff, G. W.; McMillan, A.; Matasar, M. J.; Radford, J.; Ardeshna, K. M.; Kuliczkowski, K.; Kim, W.; Hong, X. N.; Goerloev, J. S.; Davies, A.; Barrigon, M. D. C.; Ogura, M.; Fennessy, M.; Liao, Q. M.; van der Holt, B.; Lisby, S.; Lin, T. S.; Hagenbeek, A.
Abstract Title: Ofatumumab versus rituximab salvage chemoimmunotherapy in relapsed or refractory diffuse large B-cell lymphoma: The Orcharrd Study (OMB110928)
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349233806204
PROVIDER: wos
Notes: Meeting Abstract: 630 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
MSK Authors
  1. Matthew J Matasar
    122 Matasar